GTS Securities’s Gossamer Bio GOSS Stock Holding History

GTS Securities’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,627	Closed	-$27.9K	–	1551
2025 Q3	$27.9K	Buy	+10,627	New	+$23.4K	﹤0.01%	1381

Other funds holding GOSS

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

GTS Securities's GOSS Position: Q4 2025 in Review

GTS Securities sold out of Gossamer Bio (GOSS) in Q4 2025, closing a stake of 10,627 shares — an estimated $27.9K sold.

GTS Securities first reported a position in GOSS in Q3 2025 and held it in 1 quarter. The position peaked at $27.9K in Q3 2025. 195 funds tracked by Wall St. Rank hold GOSS as of Q4 2025.

GTS Securities reported no remaining Gossamer Bio position as of Q4 2025 after selling out during the quarter.
GTS Securities sold 10,627 Gossamer Bio shares in Q4 2025, an estimated $27.9K.
GTS Securities first reported a position in Gossamer Bio in Q3 2025 and held it in 1 quarter.
GTS Securities's Gossamer Bio position peaked at $27.9K in Q3 2025.
195 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2025.

Based on GTS Securities's 13F filing for Q4 2025, filed 13 Feb 2026.